Author: Nicholas Alan Clayton

new-spac
TOP-3

Oaktree II (OACB) Adds Backstops of Up to $250M to Alvotech Deal

Oaktree Acquisition Corp. II (NYSE:OACB) has added up to $250 million to its combination with biosimilar drugmaker Alvotech through two facilities to replace potential redemptions.

The backstops are made up of an $150 million standby equity purchase agreement (SEPA) from YA II PN, an affiliate of Oaktree II’s sponsor, and a binding term sheet providing $75 million to $125 million in debt from Sculptor Capital Management. ...READ MORE

dune-tradezero
new-spac
TOP-3
deal-terms-2
TOP-3
RUMORS

OnlyFans Reportedly Trying to Get into Bed With SPACs

Social content platform OnlyFans has reportedly engaged in talks with multiple SPACs, but has so far failed to seal the deal, according to a report in Axios.

The influencer platform, which is known primarily for hosting explicit sexual content, projected it could swell its income to $1.2 billion in 2021 and $2.5 billion in a March 2021 pitch deck reportedly obtained by the news service. ...READ MORE